Assyro AI

FDA Orange Book · active-ingredient family

Disopyramide phosphate

Disopyramide phosphate is approved as 2 brand and 18 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:NORPACE CR · NDA 018655

2

Brand (NDA)

18

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule, capsule, extended release

ProductApplicantApplicationTEApproved
NORPACE CRRLD×2PFIZERNDA 018655Jul 20, 1982
NORPACERLD×2PFIZERNDA 017447ABApproved Prior to Jan 1, 1982

Generic (ANDA) products (18)

ProductApplicantApplicationTEApproved
DISOPYRAMIDE PHOSPHATENESHER PHARMSANDA 071200Dec 15, 1987
DISOPYRAMIDE PHOSPHATESUPERPHARMANDA 070940Feb 09, 1987
DISOPYRAMIDE PHOSPHATESUPERPHARMANDA 070941Feb 09, 1987
DISOPYRAMIDE PHOSPHATEINTERPHARMANDA 071190Jan 15, 1987
DISOPYRAMIDE PHOSPHATEINTERPHARMANDA 071191Jan 15, 1987
DISOPYRAMIDE PHOSPHATEWATSON LABSANDA 070240Feb 02, 1986
DISOPYRAMIDE PHOSPHATEWATSON LABSANDA 070241Feb 02, 1986
DISOPYRAMIDE PHOSPHATESUN PHARM INDUSTRIESANDA 070351Dec 17, 1985
DISOPYRAMIDE PHOSPHATESUN PHARM INDUSTRIESANDA 070352Dec 17, 1985
DISOPYRAMIDE PHOSPHATERISINGANDA 070470Dec 10, 1985
DISOPYRAMIDE PHOSPHATERISINGANDA 070471Dec 10, 1985
DISOPYRAMIDE PHOSPHATEIVAX SUB TEVA PHARMSANDA 070186Nov 18, 1985
DISOPYRAMIDE PHOSPHATEIVAX SUB TEVA PHARMSANDA 070187Nov 18, 1985
DISOPYRAMIDE PHOSPHATEMYLANANDA 070138Jun 14, 1985
DISOPYRAMIDE PHOSPHATEMYLANANDA 070139Jun 14, 1985
DISOPYRAMIDE PHOSPHATE×2DR REDDYS LABS SAANDA 070173ABMay 31, 1985
DISOPYRAMIDE PHOSPHATETEVAANDA 070101ABFeb 22, 1985
DISOPYRAMIDE PHOSPHATETEVAANDA 070102ABFeb 22, 1985

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Disopyramide phosphate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.